Viewing Study NCT01217450

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-02-20 @ 5:52 PM
Study NCT ID: NCT01217450
Status: COMPLETED
Last Update Posted: 2014-05-29
First Post: 2010-10-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Colon Cancer View
None Recurrent Rectal Cancer View
None Stage IVA Colon Cancer View
None Stage IVA Rectal Cancer View
None Stage IVB Colon Cancer View
None Stage IVB Rectal Cancer View
None Unspecified Adult Solid Tumor, Protocol Specific View
Keywords: